OBJECTIVE: To assess the visualisation of the left anterior descending (LAD) coronary artery on CT images used for breast radiation treatment planning. METHODS: Delineation of the LAD artery was achieved for 25 breast patients by 1 radiologist and 1 radiation oncologist independently on two sets of images for each patient: one pre-operative CT scan using intravenous (IV) contrast media to determine the primary gross tumour volume (GTV) and one post-operative CT scan used for treatment planning. A Student's paired t-test was used to compare the number of CT slices in which the LAD was visible for each patient in the two series. Interpolations and extrapolations of the LAD volume were performed for the left-sided cases using a published heart atlas in order to report doses to the LAD structure. RESULTS: There was a non-significant difference between the results with and without IV contrast media (p=0.34 for the radiologist; p=0.90 for the radiation oncologist). The visible LAD artery corresponded to a 30% portion (range 12-47%) of the interpolated structure. The maximum dose to the left artery varied widely, from 2.7 to 41.7 Gy, in the group of patients with left breast tumours. The largest values (>25 Gy) corresponded to those patients in whom the LAD artery distal extremity lay inside the breast fields. CONCLUSIONS: With the current planning CT protocol, only one-third of the LAD artery could be objectively visualised. Contrast-enhanced imaging used for GTV delineation before the breast surgery did not improve the visualisation of the artery. ADVANCES IN KNOWLEDGE: This study has revealed the lack of consistency that may be encountered when contouring heart vessels, thereby questioning the reliability of dose reporting.
OBJECTIVE: To assess the visualisation of the left anterior descending (LAD) coronary artery on CT images used for breast radiation treatment planning. METHODS: Delineation of the LAD artery was achieved for 25 breast patients by 1 radiologist and 1 radiation oncologist independently on two sets of images for each patient: one pre-operative CT scan using intravenous (IV) contrast media to determine the primary gross tumour volume (GTV) and one post-operative CT scan used for treatment planning. A Student's paired t-test was used to compare the number of CT slices in which the LAD was visible for each patient in the two series. Interpolations and extrapolations of the LAD volume were performed for the left-sided cases using a published heart atlas in order to report doses to the LAD structure. RESULTS: There was a non-significant difference between the results with and without IV contrast media (p=0.34 for the radiologist; p=0.90 for the radiation oncologist). The visible LAD artery corresponded to a 30% portion (range 12-47%) of the interpolated structure. The maximum dose to the left artery varied widely, from 2.7 to 41.7 Gy, in the group of patients with left breast tumours. The largest values (>25 Gy) corresponded to those patients in whom the LAD artery distal extremity lay inside the breast fields. CONCLUSIONS: With the current planning CT protocol, only one-third of the LAD artery could be objectively visualised. Contrast-enhanced imaging used for GTV delineation before the breast surgery did not improve the visualisation of the artery. ADVANCES IN KNOWLEDGE: This study has revealed the lack of consistency that may be encountered when contouring heart vessels, thereby questioning the reliability of dose reporting.
Authors: C E de Almeida; N Fournier-Bidoz; C Massabeau; A Mazal; P C Canary; I R Kuroki; F Campana; A Fourquet; Y M Kirova Journal: Cancer Radiother Date: 2011-11-08 Impact factor: 1.018
Authors: Lawrence F Paszat; Katherine A Vallis; Veronique M A Benk; Patti A Groome; William J Mackillop; Andreas Wielgosz Journal: Radiother Oncol Date: 2007-02-05 Impact factor: 6.280
Authors: Sharon H Giordano; Yong-Fang Kuo; Jean L Freeman; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin Journal: J Natl Cancer Inst Date: 2005-03-16 Impact factor: 13.506
Authors: Cyrus Chargari; Krassen M Kirov; Marc A Bollet; Nicolas Magné; Lionel Védrine; Serge Cremades; Philippe Beuzeboc; Alain Fourquet; Youlia M Kirova Journal: Cancer Treat Rev Date: 2010-09-22 Impact factor: 12.111
Authors: Reshma Jagsi; Jean Moran; Robin Marsh; Kathryn Masi; Kent A Griffith; Lori J Pierce Journal: Int J Radiat Oncol Biol Phys Date: 2010-09-09 Impact factor: 7.038
Authors: Editha A Krueger; Matthew J Schipper; Todd Koelling; Robin B Marsh; James B Butler; Lori J Pierce Journal: Int J Radiat Oncol Biol Phys Date: 2004-11-15 Impact factor: 7.038
Authors: Eric D Morris; Ahmed I Ghanem; Milan V Pantelic; Eleanor M Walker; Xiaoxia Han; Carri K Glide-Hurst Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-22 Impact factor: 7.038
Authors: M E Mast; M W Heijenbrok; M L van Kempen-Harteveld; A L Petoukhova; A N Scholten; R Wolterbeek; J H M Schreur; H Struikmans Journal: Strahlenther Onkol Date: 2016-08-17 Impact factor: 3.621
Authors: Frances Duane; Marianne C Aznar; Freddie Bartlett; David J Cutter; Sarah C Darby; Reshma Jagsi; Ebbe L Lorenzen; Orla McArdle; Paul McGale; Saul Myerson; Kazem Rahimi; Sindu Vivekanandan; Samantha Warren; Carolyn W Taylor Journal: Radiother Oncol Date: 2017-02-21 Impact factor: 6.280
Authors: Xinzhuo Wang; Raymond Miralbell; Odile Fargier-Bochaton; Shelley Bulling; Jean Paul Vallée; Giovanna Dipasquale Journal: Technol Cancer Res Treat Date: 2020 Jan-Dec